A team of investigators led by researchers at Hsinchu MacKay Memorial Hospital, MacKay Medical University, and National Taiwan University analyzed data from 847 community-dwelling adults aged 53 and older who took part in the 2006 Social Environment and Biomarkers of Aging Study, a landmark Taiwanese survey known as SEBAS that integrates self-reported health information with objective biological measurements. Their question was deceptively simple: does naturally occurring variation in cortisol, measured noninvasively in overnight urine, predict osteoporosis in ordinary aging populations? Their answer, published in BMC Endocrine Disorders, was a careful and statistically robust no, at least not in any straightforward dose-response sense.

The study’s methodological strength lies in how it captured cortisol. Rather than relying on blood samples, which reflect momentary hormone spikes influenced by time of day, meals, and acute anxiety, the researchers measured cortisol in twelve-hour overnight urine specimens. They then expressed the result as a urinary cortisol-to-creatinine ratio, a standard technique that corrects for dilution differences in urine volume and provides a more stable index of integrated hormone secretion during sleep, when the confounding noise of daily activity is minimized. Creatinine, a byproduct of muscle metabolism excreted at a relatively constant rate, serves as the internal normalizing yardstick.

Participants were sorted into four groups, or quartiles, according to their cortisol-to-creatinine ratios, from lowest to highest. The average participant was 65.6 years old, and women made up 46.5 percent of the sample, a distribution well suited to studying osteoporosis, which disproportionately affects postmenopausal women. The outcome measure was self-reported osteoporosis, an acknowledged limitation, but one that captures clinically recognized diagnoses within a large, real-world population.

The statistical analysis employed multivariable logistic regression, the workhorse method of observational epidemiology. By adjusting for a panel of potential confounders, the model isolates the association between cortisol exposure and osteoporosis while holding other risk factors statistically constant. Compared with participants in the lowest cortisol quartile, the adjusted odds ratios for self-reported osteoporosis were 1.04 in the second quartile, 1.07 in the third, and 1.21 in the fourth. Although the point estimates crept upward with higher cortisol, none of the confidence intervals excluded the null value of one, meaning none of the associations reached statistical significance. A formal test for linear trend across quartiles returned a p-value of 0.463, far from the conventional threshold of 0.05, effectively ruling out a consistent gradient of risk.

The one genuinely intriguing signal emerged in exploratory subgroup analyses stratified by age. The researchers detected a statistically significant interaction by age group, with a p-value for interaction of 0.004. In plain terms, the relationship between cortisol and osteoporosis appeared to differ between younger and older participants in the sample. Yet, crucially, neither age group displayed a consistent monotonic pattern across cortisol quartiles, meaning the interaction did not resolve into a clean story of harm in one group and protection in the other. The authors themselves urge caution, noting that such findings can arise by chance in secondary analyses and require confirmation before any clinical interpretation is attempted.

Why does the broader biological hypothesis remain compelling even in the face of a null result? The hypothalamic-pituitary-adrenal axis, or HPA axis, is the body’s master stress circuit. The hypothalamus signals the pituitary gland, which in turn prompts the adrenal cortex to release cortisol. In controlled medical contexts, such as Cushing’s syndrome, where the body produces pathological excess cortisol, or during long-term glucocorticoid therapy, the bone-destroying power of the hormone is undisputed: cortisol suppresses osteoblast activity, promotes osteocyte apoptosis, and shifts the delicate balance of bone remodeling toward resorption. The open question has always been whether the subtler, physiologic range of cortisol variation seen in everyday stress reaches a threshold capable of measurable skeletal damage at the population level.

The new findings suggest that, at least as captured by a single overnight urinary measurement, ordinary endogenous cortisol variation does not register as a meaningful osteoporosis risk factor. Several explanations deserve consideration. First, a single twelve-hour urine specimen is a snapshot of HPA axis activity on one night, whereas cumulative cortisol exposure over years or decades may be what matters for bone. Repeated sampling across multiple days and time points would better approximate the long-term hormonal milieu that bone cells actually experience. Second, the outcome was self-reported osteoporosis rather than objective bone mineral density measured by dual-energy X-ray absorptiometry, the diagnostic gold standard. Misclassification of the outcome can dilute true associations toward the null. Third, the cross-sectional design captures a single moment in time, making it impossible to establish whether any hormonal difference preceded the development of bone disease.

These caveats are not reasons to dismiss the study; they are precisely the roadmap the authors propose for future work. Larger prospective cohorts with repeated cortisol measurements and direct imaging-based assessment of bone health would allow researchers to track whether HPA axis activity predicts subsequent bone loss, rather than merely coexisting with it. The SEBAS infrastructure, which links the Taiwan Longitudinal Study of Aging with biomarker collection, offers an unusually rich foundation for such inquiries, and the current analysis demonstrates both the feasibility and the limits of single-biomarker cross-sectional approaches.

The study, supported by the National Science and Technology Council, Taiwan, and approved by the Research Ethics Committee of National Taiwan University Hospital, carries practical implications for clinicians and the public alike. People worried about osteoporosis should not interpret the findings as a signal that stress is irrelevant to bone health; rather, the results indicate that a single overnight cortisol measurement is not a useful screening tool for identifying osteoporosis risk in middle-aged and older adults. Established risk factors, including age, sex, menopausal status, body weight, physical inactivity, smoking, and inadequate calcium and vitamin D intake, remain the cornerstones of risk assessment. For researchers, the study is a sobering reminder that plausible mechanisms do not guarantee detectable population effects, and that null findings, honestly reported and statistically transparent, are essential building blocks of reliable science. As the authors conclude, the exploratory age interaction and the overall null association both demand confirmation in larger, longitudinal studies before the stress-bone hypothesis can be either advanced or retired.

Subject of Research: Association of overnight urinary cortisol-to-creatinine ratio with self-reported osteoporosis in community-dwelling Taiwanese adults

Article Title: Association between the overnight urinary cortisol-to-creatinine ratio and self-reported osteoporosis in community-dwelling Taiwanese adults: a population-based cross-sectional study

Article References: Kuo, Y.-C., Chen, H.-H., Hsu, H.-Y., Wang, J., Chien, K.-L., Yeh, T.-L., Tsai, S.-Y., & Lee, Y.-S. (2026). Association between the overnight urinary cortisol-to-creatinine ratio and self-reported osteoporosis in community-dwelling Taiwanese adults: a population-based cross-sectional study. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02568-5

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02568-5

Keywords: osteoporosis, urinary cortisol-to-creatinine ratio, hypothalamic-pituitary-adrenal axis, cortisol, bone health, healthy aging, SEBAS, Taiwan, cross-sectional study, endocrinology, epidemiology, stress

Young adulthood is marked by major changes in education, employment, relationships, independence and identity. It is also a period when many psychiatric conditions emerge or intensify. Suicidal behavior rarely results from a single cause; instead, it can reflect the interaction of psychological distress, social adversity, genetic vulnerability, sleep disruption, substance use and biological stress responses. By examining these factors together across time, the study addresses a central challenge in modern psychiatry: identifying measurable processes that may help explain changes in risk before a crisis occurs.

The term “stress-response biomarkers” refers to biological measurements that provide clues about how the body detects and manages stress. One of the most important systems involved is the hypothalamic-pituitary-adrenal, or HPA, axis. When the brain perceives a threat, the hypothalamus signals the pituitary gland, which activates the adrenal glands to release cortisol and other hormones. This response is essential for survival, but repeated, prolonged or poorly regulated activation can influence sleep, immune activity, mood and brain function. Biomarkers related to this system may therefore offer a biological window into how chronic stress affects cognition and emotional regulation.

The study’s focus on neurocognitive functioning is equally significant. Neurocognition includes mental processes such as attention, working memory, processing speed, learning, decision-making and inhibitory control. These abilities help people evaluate consequences, shift perspective and regulate impulses, particularly during emotionally intense situations. Difficulties in these areas do not determine whether someone will engage in suicidal behavior, and they should never be treated as a standalone prediction tool. However, changes in cognitive control may affect how a person responds to overwhelming distress, interprets available choices or accesses support during a rapidly escalating crisis.

A longitudinal design allows researchers to move beyond a single snapshot. In a cross-sectional study, biomarker levels and cognitive performance are measured at one point, making it difficult to determine whether one changes before or after the other. A longitudinal investigation instead follows participants over time, repeatedly assessing biological and cognitive measures. This approach can reveal whether baseline stress-related biology is associated with later neurocognitive performance, whether cognitive functioning changes alongside biomarkers, or whether both reflect a third influence, such as depression, trauma exposure, medication use or sleep disturbance.

The wording of the study’s title is important because it refers to an “association,” not proof that stress biomarkers cause cognitive changes or suicidal behavior. Biological measurements are complex and can vary with the time of day, recent food intake, physical activity, illness, medication, menstrual-cycle factors and the immediate emotional environment. Cortisol, for example, follows a daily rhythm and may be influenced by both acute stress and long-term regulation of the HPA axis. Careful statistical modeling and repeated measurements are therefore essential when researchers attempt to distinguish a stable biological pattern from a temporary fluctuation.

The research is especially relevant because young adults at risk for suicidal behavior are not a biologically uniform group. Two individuals may report similar levels of suicidal thoughts while having very different histories of trauma, anxiety, depression, sleep problems, substance exposure or social support. Their stress systems may also respond differently to the same challenge. Some people may show heightened reactivity, while others may display a blunted or poorly timed response after prolonged stress. Studying this variation could help scientists understand why identical psychological symptoms can produce very different patterns of attention, decision-making and emotional control.

If stress-related biomarkers are consistently linked with neurocognitive changes, the findings could eventually support more individualized research and clinical monitoring. Such measures might help identify people who need closer assessment, guide studies of interventions that target stress regulation, or clarify why treatments work for some patients and not others. Possible approaches could include psychotherapy, sleep-focused care, physical-activity programs, medication, social-support interventions and techniques designed to improve emotional regulation. Yet biomarkers are not destiny, and no blood, saliva or physiological measurement can determine with certainty whether an individual will attempt suicide. Clinical judgment and direct, compassionate communication remain indispensable.

The study also highlights the promise and limitations of translational psychiatry, a field that seeks to connect biological mechanisms with real-world mental-health care. Translational research is most valuable when it avoids reducing complex human experiences to a single molecule or laboratory result. Stress biology can illuminate part of the pathway linking adversity to brain function, but it cannot capture the full influence of relationships, culture, economic insecurity, access to care or personal meaning. The strongest future research will likely combine biomarkers with repeated psychological assessments, cognitive testing, digital behavior measures and detailed information about participants’ environments.

By following the relationship between stress-response biology and neurocognitive functioning in young adults vulnerable to suicidal behavior, Toukhy, Jia-Richards, Goodfriend and their colleagues contribute to a growing effort to understand suicide risk as dynamic rather than fixed. The broader message is both scientifically ambitious and clinically cautious: the body’s response to stress may be connected to how the brain manages information and emotion, but that connection must be studied over time and interpreted within the person’s life context. As researchers continue to map these pathways, the ultimate goal is not to label individuals by biology, but to detect suffering earlier and expand opportunities for effective, timely support.

Subject of Research: The longitudinal association between stress-response biomarkers and neurocognitive functioning in young adults at risk for suicidal behavior.

Article Title: The longitudinal association of stress-response biomarkers on neurocognitive functioning in young adults at-risk for suicidal behavior.

Article References: Toukhy, N., Jia-Richards, M., Goodfriend, E. et al. “The longitudinal association of stress-response biomarkers on neurocognitive functioning in young adults at-risk for suicidal behavior.” Translational Psychiatry (2026). https://doi.org/10.1038/s41398-026-04365-z

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04365-z

Acute stress is a ubiquitous phenomenon with far-reaching consequences on both brain and body. It activates the hypothalamic-pituitary-adrenal (HPA) axis, culminating in the secretion of cortisol—a glucocorticoid pivotal to the body’s stress response. Cortisol orchestrates a wide range of systemic adaptations to acute stress, impacting metabolism, immune function, and neural processing. Yet, its role in modulating alcohol consumption remains a nuanced territory shaped by individual histories and genetic vulnerabilities. Weckesser and colleagues embark on elucidating these subtleties through an exhaustive review, bringing together studies that span experimental stress paradigms, observational data, and clinical assessments.

Central to their findings is the differentiated cortisol response to acute stress in individuals with a personal history of AUD compared to those with familial risk or no such history. The meta-analysis reveals that personal AUD is associated with blunted cortisol reactivity under stress, suggesting an attenuated HPA axis response. This dysregulation potentially impairs the feedback mechanisms that typically mitigate stress, fostering a biological environment conducive to maladaptive alcohol use. In contrast, familial risk without personal AUD does not exhibit significant alteration in cortisol dynamics, indicating a critical distinction in neuroendocrine response patterns that may forecast vulnerability versus resilience.

The behavioral ramifications of cortisol fluctuations under stress are pivotal to understanding alcohol consumption trajectories. The research consolidates evidence that acute stress can potentiate craving and drinking behavior, but the magnitude of this effect is modulated by cortisol reactivity profiles. Individuals with hypoactive cortisol responses may engage in compensatory alcohol use as a maladaptive attempt to achieve homeostasis or dampen psychological distress. This aligns with contemporary models positing that dysregulated stress hormone systems form a biological substrate for stress-induced alcohol misuse.

Moreover, the interplay between cortisol and reward pathways emerges as a key mechanistic insight. Cortisol interacts with dopaminergic circuits in the brain’s reward system, influencing reinforcement learning and motivational states. Disruptions in cortisol signaling may therefore alter the hedonic valuation of alcohol, escalating risk for excessive consumption during stressful periods. This implies a bidirectional feedback loop where stress hormones not only mediate physiological adaptation but also modulate addictive behaviors, a facet richly dissected in the meta-analytic data.

Methodologically, Weckesser et al.’s rigorous approach stands out. They aggregate data from multiple studies employing standardized acute stress induction techniques such as the Trier Social Stress Test (TSST) and pharmacological challenges, ensuring comparability. The meta-analytic framework accounts for heterogeneity across study populations, stress modalities, and alcohol consumption measures, thereby enhancing the robustness of conclusions. Their statistical modeling controls for confounders such as age, sex, and baseline drinking habits, painting a finely grained portrait of the cortisol-alcohol-stress nexus.

The implications of these findings extend far beyond academic inquiry. They offer tangible targets for clinical intervention—identifying HPA axis dysfunction as a biomarker for stress-related drinking vulnerability could pave the way for personalized therapeutic strategies. Pharmacological modulation of cortisol responses or stress management techniques tailored to neuroendocrine profiles might reduce relapse rates and improve treatment outcomes for individuals battling AUD. Importantly, the differential patterns noted among familial risk groups hint at windows for preventative efforts before pathological drinking commences.

Interestingly, the review also casts light on individuals with no history or familial risk of AUD, demonstrating relatively normative cortisol responses to acute stress. This baseline serves as a control benchmark, underscoring that dysregulation is not an inevitable consequence of stress exposure but rather a marker of pathological vulnerability. Understanding this distinction enriches the landscape of risk assessment and supports a nuanced appreciation of individual variability in alcohol-related stress response.

Another key contribution of this meta-analysis is its exploration of the temporal dynamics of cortisol release and alcohol intake post-stress. The authors synthesize findings that cortisol peaks typically precede or coincide with increases in drinking urge, proposing temporally coordinated windows for intervention. This temporal dimension adds depth to our understanding of how stress hormones dynamically drive behavior, reinforcing the value of monitoring cortisol levels in real-time scenarios to anticipate risky drinking episodes.

The neurobiological mechanisms underpinning these phenomena are further contextualized by the authors within the broader framework of stress-related psychopathology. They discuss how prolonged or repeated stress can recalibrate the HPA axis, possibly leading to allostatic load that perpetuates maladaptive behaviors including excessive alcohol use. This conceptualization situates their findings in the wider discourse on stress as a fundamental driver of mental health disorders and addiction, underscoring the integrative nature of the research.

From a public health perspective, these insights also resonate significantly. By clarifying the link between acute stress and problematic alcohol consumption, particularly in vulnerable populations, the review emphasizes the importance of stress mitigation strategies at community and policy levels. Stress reduction interventions, mental health promotion, and accessible treatment services tailored for high-risk groups may collectively attenuate the societal burden of AUD.

Technological advancements in cortisol measurement are likely to catalyze future research trajectories suggested by this meta-analysis. Non-invasive sampling methods alongside real-time biosensors could revolutionize how clinicians and researchers track stress physiology and its behavioral consequences. The study by Weckesser et al. sets a crucial empirical foundation upon which these innovations can be integrated, facilitating dynamic monitoring and personalized interventions.

While the meta-analysis offers profound clarity, it also identifies gaps in the literature warranting further inquiry. Notably, the interaction between other stress-related neuroendocrine factors—such as catecholamines and neuropeptides—and alcohol consumption is less understood. Moreover, sex differences in cortisol response and their relation to alcohol use emerge as an area ripe for exploration, as hormonal variation across genders may differentially modulate these pathways.

In sum, this landmark review and meta-analysis craft a compelling narrative linking acute stress, cortisol physiology, and alcohol consumption within at-risk populations. Weckesser and colleagues have marshaled extensive empirical evidence to reveal how stress-induced neuroendocrine dysfunctions shape the trajectory of alcohol use disorders, carving pathways toward novel diagnostic and therapeutic horizons. Their work invites a paradigm shift, viewing stress and alcohol interaction not as isolated phenomena but as deeply intertwined bio-behavioral processes with profound clinical significance.

As accumulating evidence continues to underscore the centrality of stress hormone regulation in addiction, interdisciplinary approaches integrating neuroendocrinology, psychiatry, and behavioral science will be essential. The findings presented compel the scientific community to rethink prevention and intervention strategies, focusing keenly on stress biology as a cornerstone of addiction vulnerability and resilience.

Unlocking the mechanisms by which cortisol orchestrates the dance between stress and alcohol opens unprecedented possibilities. From advanced biomarker discovery to precision medicine targeting HPA axis modulation, the future of addiction treatment holds promise for transforming lives. This meta-analytic synthesis stands as a testament to how integrative research can unravel complex biopsychosocial puzzles and inspire innovative pathways toward health and well-being.

Subject of Research: The relationship between acute stress, alcohol consumption, and cortisol levels in individuals with personal, familial, or no alcohol use disorder.

Article Title: A systematic review with meta-analysis on the relation between acute stress, alcohol consumption and cortisol levels in individuals with a personal, familial or no alcohol use disorder.

Article References:
Weckesser, L.J., Pilhatsch, M., Muehlhan, M. et al. A systematic review with meta-analysis on the relation between acute stress, alcohol consumption and cortisol levels in individuals with a personal, familial or no alcohol use disorder. Transl Psychiatry 15, 423 (2025). https://doi.org/10.1038/s41398-025-03641-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-025-03641-8

The study hinges on validating monosynaptic connections between the DPd and PVH CRH neurons, pivotal players in the regulation of the hypothalamic-pituitary-adrenal (HPA) axis. Employing channelrhodopsin-assisted circuit mapping (CRACM) paired with anterograde trans-synaptic tracing, researchers injected Cre-dependent AAV1 virus expressing tdTomato into CRH-Cre mouse lines to fluorescently label CRH neurons within the PVH. Concurrently, AAV-ChR2-YFP constructs were introduced into the DPd to render its axonal projections photosensitive. After allowing for viral expression, electrophysiological recordings from fluorescently labeled CRH neurons were made in acute brain slices while stimulating DPd axon terminals optogenetically.

The electrophysiological experiments revealed a high fidelity of monosynaptic connectivity; specifically, 12 out of 14 recorded CRH neurons responded with significant postsynaptic currents to photostimulation of DPd fibers. The average response amplitude was measured at 83 ± 21 picoamperes, corroborating a direct excitatory influence from DPd onto PVH CRH neurons. This finding definitively establishes a monosynaptic link between cortical areas and hypothalamic neuroendocrine cells, a connection critical for understanding brain-body communication during stress.

Seeking to unravel the upstream signals regulating DPd activity, the investigators focused on two limbic structures intimately involved in cognitive and emotional aspects of stress: the ventral subiculum, a hippocampal output region implicated in psychological stress responses, and the anterior basolateral amygdala, known for its role in fear conditioning. Using AAV1-Cre mediated trans-synaptic tagging combined with multifluorescent anterograde tract tracing, evidence was provided that subsets of DPd neurons receive converging inputs from both the SUBv and BLAa.

Detailed anatomical reconstructions demonstrated that postsynaptic DPd neurons integrating inputs from these limbic structures send robust projections to the PVH. This anatomical convergence suggests a mechanism by which emotional and contextual information from the limbic system can be funneled through DPd neurons to directly modulate hypothalamic function, thereby bridging cognitive and endocrine realms. Notably, unidirectional projections from the BLAa and SUBv to the DPd emphasize a hierarchical flow of information supportive of this regulatory axis.

To move beyond anatomical correlation and validate the functional significance of this pathway, a sophisticated virus-based intersectional approach was deployed. AAV1-Cre viruses were injected into the SUBv and BLAa, while a Cre-dependent AAV-ChR2 was injected into the DPd. This strategy resulted in expression of channelrhodopsin specifically in DPd neurons receiving inputs from SUBv and BLAa—effectively isolating the postsynaptic subpopulation that integrates these upstream signals.

Optogenetic activation of these defined DPd neurons in vivo yielded a compelling physiological outcome: a statistically significant increase in plasma corticosterone (CORT) levels, a hallmark glucocorticoid hormone released in response to HPA axis activation during stress. This elevation in CORT was markedly higher compared to control animals, verified by rigorous statistical testing (p < 0.005), underscoring the capability of this DPd-mediated pathway to dynamically influence neuroendocrine output.

The functional circuit described thus concretely links limbic inputs, cortical integrative centers, and hypothalamic neuroendocrine effectors, revealing a hierarchical yet rapid communication system that may orchestrate stress hormone release in response to environmental and psychological cues. The findings coincide with recent chemogenetic studies showing that stimulation of DP/TTd increases plasma corticosterone, strengthening the hypothesis of the DPd as a critical visceromotor cortex node governing neuroendocrine responses.

This research significantly expands the burgeoning literature that positions the dorsal peduncular cortex as a visceromotor hub, previously underappreciated in its role in modulating physiological states. By unraveling the precise wiring from limbic areas through the DPd to hypothalamic CRH neurons, the study provides a mechanistic foundation for understanding how emotional and contextual factors influence systemic hormonal milieu.

Moreover, these insights contribute to a deeper comprehension of stress-related disorders where dysregulation of the HPA axis is prevalent, including anxiety, depression, and post-traumatic stress disorder. Understanding the cortical and limbic control over hypothalamic neuroendocrine cells opens avenues for targeted therapies that modulate this circuitry to ameliorate maladaptive stress responses.

The methodological rigor exemplified in this study—combining optogenetics, viral circuit tracing, electrophysiology, and endocrine assays—sets a new standard for dissecting complex neuroendocrine circuits. The multidimensional approach validates both anatomical connectivity and functional outcomes, a critical balance in neuroscience research translating cellular circuits to physiological phenomena.

Additionally, the evidence for convergent inputs from SUBv and BLAa onto the same DPd neurons suggests an integrative node that amalgamates diverse streams of information, potentially encoding the salience and emotional valence of stressors before transmission to hypothalamic effectors. Such integration is fundamental to adaptive responses that match hormonal output with the organism’s internal and external milieu.

In sum, this pioneering work elucidates a detailed visceromotor cortical circuit that bridges the limbic forebrain with hypothalamic neuroendocrine cells, highlighting the DPd’s pivotal role in regulating stress hormone release. This paradigm enriches our understanding of brain-body interaction under stress and offers promising targets for modulating neuroendocrine function in disease states.

Subject of Research: Neural circuit regulation of hypothalamic neuroendocrine cells by limbic and cortical inputs in the mouse brain.

Article Title: Neural networks of the mouse visceromotor cortex.

Article References:
Hintiryan, H., Zhu, M., Zhao, P. et al. Neural networks of the mouse visceromotor cortex. Nature (2025). https://doi.org/10.1038/s41586-025-09360-w

Image Credits: AI Generated